Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1686 of 5804
-
New immune therapy combo aims to tame chronic GVHD in Steroid-Resistant patients
Disease control OngoingThis research study is a Phase I clinical trial, which tests the safety of an investigational combination of IL-2 plus donor anti-inflammatory Treg cells and also tries to define the appropriate dose of the investigational combination of IL-2 plus donor anti-inflammatory Treg cel…
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Proton beam therapy aims to cut prostate cancer treatment time and side effects
Disease control OngoingThis phase II trial studies the side effects and how well hypofractionated proton beam radiation therapy works in treating patients with prostate cancer that has not spread to nearby lymph nodes or to other parts of the body. Specialized radiation therapy, such as proton beam rad…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Triple-Drug cocktail aims to stall endometrial cancer
Disease control OngoingThe goal of this clinical research study is to learn if the combination of everolimus, letrozole, and metformin can help to control recurrent or progressive endometrial cancer. The safety of this drug combination will also be studied. Everolimus is designed to block a protein in…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Massive VA trial tests cheap ways to protect kidneys during heart procedures
Prevention CompletedThe purpose of this research study is to compare the effectiveness of intravenous isotonic sodium bicarbonate with intravenous isotonic sodium chloride and oral N-acetylcysteine (NAC) with oral placebo for the prevention of serious adverse outcomes following angiographic procedur…
Phase: PHASE3 • Sponsor: VA Office of Research and Development • Aim: Prevention
Last updated Jun 27, 2026 07:56 UTC
-
Battle of the balloons: which achalasia treatment wins?
Disease control CompletedThe aim of the study is to compare the efficacy of per-oral endoscopic myotomy (POEM) to the efficacy of pneumodilation as the initial treatment of symptomatic idiopathic achalasia. It is hypothesized that POEM has a higher long-term efficacy than pneumodilation in treatment of t…
Phase: NA • Sponsor: KU Leuven • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New drug cocktail shows promise for Hard-to-Treat lymphoma
Disease control OngoingThis phase I trial studies the side effects and best dose of lenalidomide and ibrutinib in treating patients with B-cell non-Hodgkin lymphoma that has returned (relapsed) or not responded to treatment (refractory). Lenalidomide helps shrink or slow the growth of non-Hodgkin lymph…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New drug shows promise in slowing rare carcinoid tumors
Disease control OngoingThis randomized phase II trial studies how well pazopanib hydrochloride works in treating patients with carcinoid tumors that are growing, spreading, or getting worse. Pazopanib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growt…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Brain mapping breakthrough: combining scans and implants to improve epilepsy surgery
Knowledge-focused CompletedThe SEMAINE project will investigate intracranial EEG (icEEG) simultaneously recorded with either fMRI or MEG to 1) improve identification of the epileptogenic zone in patients suffering from drug-resistant partial epilepsy, and 2) define the functional organization of neural net…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:38 UTC
-
Blood test could replace risky food challenges for kids with allergies
Diagnosis CompletedChild food allergy represent 6 to 8% of child in industrialised country. Within this allergy, peanuts and egg allergy are one of the most common. Actually when there is a suspicion of food allergy, the OPT is the gold standard for the diagnosis. During the OPT we give increasing…
Phase: PHASE4 • Sponsor: University Hospital, Rouen • Aim: Diagnosis
Last updated Jun 27, 2026 12:08 UTC
-
Could an iron scavenger slow ALS?
Disease control CompletedThe FAIR-ALS study is to investigate the safety and efficacy of a scavenger treatment of iron deferiprone, which would reduce the brain iron to limit the development of amyotrophic lateral sclerosis. It has been shown an excess of iron in the central nervous system carrying a sp…
Phase: PHASE2 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
10-Year Check-In: cell treatment for knee arthritis shows promise
Disease control CompletedThis is an interventional study to treat knees osteoarthritis (KOA) with adipose-derived stromal vascular fraction cell components in sixteen subjects with either unilateral or bilateral symptomatic Kellgren Lawence Grade 3 KOA by intra-articular injection of knees. Later, subjec…
Phase: PHASE1, PHASE2 • Sponsor: Michael H Carstens • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Could a chemo combo slow pancreatic tumor growth?
Disease control OngoingThis randomized phase II trial studies how well giving temozolomide with or without capecitabine works in treating patients with advanced pancreatic neuroendocrine tumors. Drugs used in chemotherapy, such as temozolomide and capecitabine, work in different ways to stop the growth…
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Muscle loss in cirrhosis: could a simple amino acid drink be the answer?
Disease control Recruiting nowLoss of skeletal muscle mass or sarcopenia is the most common and potentially reversible complication in cirrhosis that increases morbidity and mortality before, during and after liver transplantation. No proven treatments exist for the prevention or reversal of sarcopenia in cir…
Phase: NA • Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Better swab, better catch: study aims to sharpen anal cancer screening
Diagnosis OngoingThis clinical trial compares three anal cytology collection procedures (collected at a single visit) in men who have sex with men (MSM). It also compares two different tests for human papilloma virus, the virus that causes high grade anal dysplasia, which is thought to occur befo…
Phase: NA • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
Engineered t cells take on childhood cancer in early trial
Disease control OngoingSubjects that have relapsed or refractory neuroblastoma are invited to take part in this gene transfer research study. We have found from previous research that we can put a new gene called a chimeric antigen receptor (CAR) into T cells that will make them recognize neuroblastom…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Ultrasound could help women avoid unnecessary repeat C-Sections
Knowledge-focused CompletedThe rate of caesarians dramatically increased for 15 years. The main indication of caesarian became the iterative caesarian of principle because of a history of caesarian. Any attempt of reduction of the rate of caesarians should thus focus on the indications of iterative princip…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:13 UTC
-
New combo therapy may help liver cancer patients bridge to transplant
Disease control OngoingThis trial is designed to be the initial prospective pilot investigation of the effectiveness of combined SBRT and TACE as bridging therapy for HCC patients awaiting liver transplanation. No prospective clinical trials regarding the combination of TACE and SBRT in pre-transplant …
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Experimental drug cocktail targets tough childhood cancers in adults
Disease control CompletedThis research study is a Three arm Phase I clinical trial, which tests the safety of an investigational drug or combination of drugs and also tries to define the appropriate dose of the combination of investigational drugs to use for further studies. "Investigational" means that …
Phase: PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Can a simple test match the right chemo to each breast cancer patient?
Knowledge-focused OngoingTriple negative breast cancer (TNBC) is a difficult to treat molecular subtype with a poor survival. TNBC can be divided into at least two molecular entities; BRCA-like and non-BRCA-like. In this trial we would like to investigate whether a molecular subgroup exists within TNBCs …
Phase: PHASE2 • Sponsor: The Netherlands Cancer Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
Spinal stimulation plus drug may restore arm function in paralysis
Symptom relief OngoingThis study is designed to assess the strategy of using spinal cord stimulation to improve the ability to move in spinal cord injured humans.
Phase: PHASE1, PHASE2 • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC